Surgical management of metastatic colon cancer: A population-based analysis

Journal of Geriatric Oncology

Volumn 6, Issue 6, 2015, Pages 446-453

  Khan, Hadi ^a   Khan, Noman ^d   Ahmad, Ali ^a   Olszewski, Adam J ^b   Somasundar, Ponnandai ^a,c  

^a ROGER WILLIAMS MEDICAL CENTER   (United States)

^b MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Flushings Hospital   (United States)

Author keywords

Colon cancer; Epidemiology; Metastasectomy

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AFRICAN; AGE DISTRIBUTION; AGED; AMERICAN; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CAUCASIAN; COLON CANCER; COLON RESECTION; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HEALTH SURVEY; HISPANIC; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS RESECTION; METASTATIC COLON CANCER; MIDDLE AGED; NODAL METASTASIS; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; SURGICAL TECHNIQUE; VERY ELDERLY; CANCER STAGING; COLONIC NEOPLASMS; EVALUATION STUDY; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL ANALYSIS; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; METASTASECTOMY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84939856931     PISSN: 18794068     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgo.2015.08.002     Document Type: Article

References (27)

1. Siegel R., Desantis C., Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014, 64:104-117. 10.3322/caac.21220.
2. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004, 239:818-825. [discussion 825-817].
3. Benson A.B., Venook A.P., Bekaii-Saab T., et al. Colon cancer, version 3.2014. J Natl Compr Canc Netw 2014, 12:1028-1059.
4. Tomlinson J.S., Jarnagin W.R., DeMatteo R.P., et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007, 25:4575-4580. 10.1200/JCO.2007.11.0833.
5. Choti M.A., Sitzmann J.V., Tiburi M.F., et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002, 235:759-766.
6. Fong Y., Fortner J., Sun R.L., Brennan M.F., Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999, 230:309-318. [discussion 318-321].
7. Feroci F., Fong Y. Use of clinical score to stage and predict outcome of hepatic resection of metastatic colorectal cancer. J Surg Oncol 2010, 102:914-921. 10.1002/jso.21715.
8. Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2014 Sub (1973-2012 varying) - Linked To County Attributes - Total U.S., 1969-2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission. http://www.seer.cancer.gov.
9. McNutt L.A., Wu C., Xue X., Hafner J.P. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003, 157:940-943.
10. Robbins A.S., Chao S.Y., Fonseca V.P. What's the relative risk? A method to directly estimate risk ratios in cohort studies of common outcomes. Ann Epidemiol 2002, 12:452-454.
11. Cronin K.A., Feuer E.J. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. Stat Med 2000, 19:1729-1740.
12. Giobbie-Hurder A., Gelber R.D., Regan M.M. Challenges of guarantee-time bias. J Clin Oncol 2013, 31:2963-2969. 10.1200/JCO.2013.49.5283.
13. White I.R., Royston P., Wood A.M. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011, 30:377-399. 10.1002/sim.4067.
14. Khan H., Olszewski A.J., Somasundar P. Lymph node involvement in colon cancer patients decreases with age; a population based analysis. Eur J Surg Oncol 2014, 40:1474-1480. 10.1016/j.ejso.2014.06.002.
15. Rahbari N.N., Reissfelder C., Schulze-Bergkamen H., et al. Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy. BMC Cancer 2014, 14:174. 10.1186/1471-2407-14-174.
16. House M.G., Ito H., Gonen M., et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg 2010, 210. [744-752, 752-745]. 10.1016/j.jamcollsurg.2009.12.040.
17. Hwang M., Jayakrishnan T.T., Green D.E., et al. Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease. Eur J Cancer 2014, 50:1747-1757. 10.1016/j.ejca.2014.03.277.
18. Mayo S.C., Heckman J.E., Shore A.D., et al. Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis. Surgery 2011, 150:204-216. 10.1016/j.surg.2011.06.013.
19. Adam R., Frilling A., Elias D., et al. Liver resection of colorectal metastases in elderly patients. Br J Surg 2010, 97:366-376. 10.1002/bjs.6889.
20. Cannon R.M., Martin R.C., Callender G.G., McMasters K.M., Scoggins C.R. Safety and efficacy of hepatectomy for colorectal metastases in the elderly. J Surg Oncol 2011, 104:804-808. 10.1002/jso.22042.
21. Indrakusuma R., Dunker M.S., Peetoom J.J., Schreurs W.H. Evaluation of preoperative geriatric assessment of elderly patients with colorectal carcinoma. A retrospective study. Eur J Surg Oncol 2015, 41:21-27. 10.1016/j.ejso.2014.09.005.
22. Badgwell B., Stanley J., Chang G.J., et al. Comprehensive geriatric assessment of risk factors associated with adverse outcomes and resource utilization in cancer patients undergoing abdominal surgery. J Surg Oncol 2013, 108:182-186. 10.1002/jso.23369.
23. Kim S.W., Han H.S., Jung H.W., et al. Multidimensional frailty score for the prediction of postoperative mortality risk. JAMA Surg 2014, 149:633-640. 10.1001/jamasurg.2014.241.
24. Chapman A.E., Swartz K., Schoppe J., Arenson C. Development of a comprehensive multidisciplinary geriatric oncology center, the Thomas Jefferson University Experience. J Geriatr Oncol 2014, 5:164-170. 10.1016/j.jgo.2014.01.003.
25. Papamichael D., Audisio R.A., Glimelius B., et al. Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann Oncol 2015, 26:463-476. 10.1093/annonc/mdu253.
26. Nordlinger B., Sorbye H., Glimelius B., et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 2013, 14:1208-1215. 10.1016/S1470-2045(13)70447-9.
27. Folprecht G., Gruenberger T., Bechstein W.O., et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 2010, 11:38-47. 10.1016/S1470-2045(09)70330-4.